Recent Event

<>

November 14, 2017

New York, NY

HBS Healthcare Alumni Association

Panelist : Norman Shelby

Real Endpoints LLC

Immuno-oncology treatments have provided renewed hope to cancer patients. Combination treatments bring the promise of increased efficacy with manageable side effects. Come hear from experts about what the future may bring. 

Moderator Norman Selby, Board of Trustees at Memorial Sloan Kettering, Executive Chairman of RealEndpoints and PAIGE.AI, former Senior Partner at McKinsey.

Panelists: Sophie Opdyke, VP, Immuno-Oncology Lead, Global Commercial Development at Pfizer Umer Raffat, Managing Director at Evercore ISI Peter Bach, Director, Center for Health Policy and Outcomes at MSK.

view event >

Recent Events

April 27, 2025 - May 1, 2025

Las Vegas, NV

The Real Endpoints team will be on the ground for Asembia’s AXS25 Summit April 27 – May 1 to discuss market access, pricing and contracting, and patient support services.

view event >

April 28, 2024 - May 2, 2024

Las Vegas, NV

ASX24

The Real Endpoints team will be on the ground for Asembia’s AXS24 Summit April 28 – May 2 to discuss market access, pricing and contracting, and patient support services.

April 15, 2024 - April 17, 2024

Cambridge, UK

Jeff Berkowtiz, CEO

The ABI conference is an annual invitation-only gathering of industry leaders, scientists and inventors, and innovators that alternates between Cambridge UK and Cambridge US. On April 16, CEO Jeff Berkowitz will present a talk, “Paying for Innovation.”

view event >

April 15, 2024 - April 18, 2024

New Orleans, LA

Rob O'Brien, SVP Specialty

On April 17, Rob O’Brien will join payers and thought leaders at this year’s annual AMCP meeting to discuss prescription digital therapeutics and how to prepare for coverage.

view event >

January 7, 2024

San Francisco, CA

Jeff Berkowitz, CEO

Real Endpoints

Real Endpoints CEO, Jeff Berkowitz to be participating in the Sachs NIF at JPM24. Given the level of innovation in CNS, it’s a timely discussion.

view event >

November 17, 2023

Chicago, IL

Rob O'Brien, SVP Specialty

A day-long meeting in Chicago focused on healthcare and pharmaceutical marketplace trends, including a review of the specialty pipeline, implications of the IRA, and potential pharmaceutical disruptions. Rob O’Brien, SVP of Specialty, presenting.

view event >